Trade Show
Vendor-Neutral Plan Preparation
ASTRO® 2025 | San Francisco, California | September 28 - 30
Webinar
The Clinical Role of Dosimetry in Theranostics: A Radiation Oncologist's Perspective
Wednesday, September 3, 2025 | 2 - 3 p.m. ET
Introducing LesionID™ Pro* with Automated Zero-Click Pre-Processing
News
This update* is designed to help physicians personalize patient care by providing clear insights for theranostic treatments. Read the press release to learn how LesionID Pro fits into the Theranostics care path.
*LesionID Pro with automated zero-click pre-processing is 510(k)-pending with the U.S. FDA. Not CE Marked and not licensed in accordance with Canadian law. Not available for sale in the United States, Europe, Canada, or any other region.
GE HealthCare Advances Precision Care with MIM Encore™ to Deliver Next-Generation Digital Imaging and Workflow Solutions
News
GE HealthCare expands precision care capabilities with its first combined software release with MIM Encore, helping enhance digital imaging and workflow solutions across oncology, cardiology, and neurology.
Read MoreGE HealthCare's MIM Software Announces FDA Clearance of New Centiloid Scaling Tool to Quantify Amyloid Plaque in Brain Imaging
News
Amyloid PET radiotracers help visualize amyloid plaque density in patients being evaluated for Alzheimer’s disease.
Read More
